Buy Arava
Arava

$1.54
Active Ingredient
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Arava Properties

Active Ingredients
Leflunomide
Primary Category
Arthritis, Immunosuppressants
Therapeutic Class
Musculoskeletal, Antirheumatic Agents, DMARDs
Pharmacological Class
Immunosuppressant, Pyridine Synthesis Inhibitor
Indications
Rheumatoid Arthritis, Psoriatic Arthritis
Contraindications
Pregnancy, Severe Liver Disease, Severe Immune Problems
Minor Side Effects
Diarrhea, Nausea, Hair Loss, Rash
Moderate Side Effects
Liver Enzyme Increase, High Blood Pressure, Headache
Serious Side Effects
Severe Liver Damage, Severe Infections, Lung Problems, Low Blood Cell Counts
Dosage Forms
Tablets
Administration Route
Oral
Mechanism of Action
Helps reduce inflammation and prevent joint damage by suppressing the immune system. It works by blocking an enzyme needed for certain immune cells to grow.
Prescription Status
Rx
Manufacturer
Sanofi
Patient Summary
A medication used to reduce joint inflammation and slow the progression of joint damage in adults with rheumatoid arthritis and psoriatic arthritis.
Onset Time
May take several weeks to months for full effect
Duration
Long half-life, effects persist after stopping
Storage Instructions
Store at room temperature
Drug Interactions
Methotrexate, Live Vaccines, Warfarin
Age Restrictions
Adults
Pregnancy Use
Should not be used during pregnancy. Requires washout period before pregnancy.
Alternative Drugs
Methotrexate, Sulfasalazine

About Arava

Navigating rheumatoid arthritis treatment options can feel overwhelming, especially when distinguishing between brand-name medications like Arava and their generic counterparts. This guide examines Arava, containing the active ingredient leflunomide, which has become a significant treatment option for Singaporean patients with moderate to severe rheumatoid arthritis. We'll explore how this disease-modifying antirheumatic drug (DMARD) functions, compare it with alternatives, and provide practical information about its use in Singapore's healthcare context.

The Evolution of Arava in Rheumatoid Arthritis Management

Arava entered the global market in 1998 after receiving FDA approval, representing a significant addition to the rheumatoid arthritis treatment landscape. Developed by Sanofi (formerly Sanofi-Aventis), it was one of the first selective immunomodulators specifically designed for rheumatoid arthritis that didn't require the frequent laboratory monitoring associated with earlier medications like methotrexate. In Singapore, Arava has been available since the early 2000s and is recognized by the Health Sciences Authority (HSA) as a prescription-only medication.

What distinguishes Arava in Singapore's market is its established track record spanning over two decades. While newer biologics and JAK inhibitors have emerged in recent years, Arava maintains its place in treatment protocols, often prescribed after patients have tried methotrexate but before advancing to more expensive biologic treatments. This positioning reflects Singapore's step-therapy approach to managing healthcare costs while ensuring effective treatment options remain accessible.

Understanding How Arava Works: The Science Simplified

Leflunomide, Arava's active ingredient, tackles rheumatoid arthritis through a unique mechanism that distinguishes it from other DMARDs. At its core, leflunomide targets an enzyme called dihydroorotate dehydrogenase (DHODH), which plays a critical role in the rapid multiplication of certain immune cells, particularly activated T-lymphocytes.

Think of your immune system as an army with different specialized units. In rheumatoid arthritis, certain units (T-cells) become overactive and mistakenly attack your joint tissues. Leflunomide essentially restricts these problematic T-cells' ability to reproduce rapidly by limiting their access to essential building materials (pyrimidines). This selective approach helps reduce inflammation and slow joint damage without completely suppressing the entire immune system.

Within the body, leflunomide converts to its active form called teriflunomide, which then remains active for an extended periodโ€”sometimes weeks or even months. This explains both why Arava takes time to show its full effect (typically 4-8 weeks) and why a special elimination procedure may be needed if you need to clear the medication quickly from your system.

Who Benefits Most from Arava Treatment?

Arava is primarily prescribed for adult patients with moderate to severe active rheumatoid arthritis who haven't responded adequately to first-line treatments like methotrexate. The ideal candidate profile typically includes:

Patients with progressive disease: Consider Mrs. Tan, a 48-year-old teacher who initially managed her mild rheumatoid arthritis with NSAIDs and low-dose methotrexate. When she began experiencing increased joint swelling, morning stiffness lasting over an hour, and difficulty gripping classroom materials, her rheumatologist recognized these as signs of disease progression requiring more targeted treatment.

Those seeking oral medication alternatives: For patients like Mr. Lee, a 55-year-old business traveler, injectable medications prove challenging due to his frequent international trips. Arava's oral administration provides a convenient alternative that doesn't require refrigeration or injection equipment.

Patients with certain contraindications to methotrexate: Ms. Lim, a 42-year-old accountant with liver enzyme abnormalities, couldn't tolerate methotrexate due to consistent elevation in her liver function tests. Arava offered her an alternative DMARD option, though her doctor still monitors her liver function regularly.

Arava is generally not prescribed for pregnant women or those planning pregnancy, patients with severe immunodeficiency, bone marrow dysfunction, or significant liver disease. It's also typically avoided in patients with serious active infections.

Arava vs. Generic Leflunomide: Beyond the Active Ingredient

While Arava and generic leflunomide contain the identical active substance, several important differences exist:

Formulation and inactive ingredients: Arava contains specific excipients like lactose monohydrate, corn starch, and magnesium stearate. Generic versions might use different binding agents or fillers. For most patients, these differences are inconsequential, but individuals with specific sensitivities to certain inactive ingredients should review the complete formulation.

Physical characteristics: Arava tablets have a distinctive appearanceโ€”10mg tablets are white to off-white and round, 20mg tablets are yellowish to ochre and triangular. Generic tablets may have different colors, shapes, or markings depending on the manufacturer.

Manufacturing standards and consistency: As the originator product, Arava undergoes Sanofi's standardized quality control processes. Generic manufacturers must demonstrate bioequivalence to regulatory authorities, but slight variations in manufacturing processes may theoretically lead to minor differences in dissolution or absorption in some individuals.

Cost difference: In Singapore, generic leflunomide typically costs 30-50% less than brand-name Arava. For example, a month's supply of Arava 20mg might cost approximately S$120-180, while generic versions often range from S$60-120, though prices vary between pharmacies and with insurance coverage.

Patient perception: Some patients report subjective differences when switching between brand and generic versions. While scientifically these products should have equivalent effects, factors like the nocebo effect (expecting negative outcomes) or subtle formulation differences might contribute to these perceptions in some individuals.

Comparing Treatment Options: Arava and Alternatives

When considering Arava against other rheumatoid arthritis medications available in Singapore, several factors merit consideration:

Medication Mechanism Administration Typical Cost/Month Monitoring Requirements Time to Efficacy
Arava (Leflunomide) DHODH inhibitor Oral, once daily S$120-180 Liver function, blood counts, blood pressure 4-8 weeks
Methotrexate Dihydrofolate reductase inhibitor Oral or injectable, weekly S$30-80 Liver function, blood counts, lung function tests 4-12 weeks
Hydroxychloroquine Multiple (affects lysosomal activity) Oral, daily S$40-70 Eye exams, blood counts 2-6 months
Sulfasalazine Multiple (anti-inflammatory) Oral, 2-3 times daily S$30-60 Liver function, blood counts 2-3 months
Biologics (e.g., Humira) Targeted immune modulation Injectable, weekly/biweekly S$1,500-2,500 TB screening, infection monitoring 2-12 weeks

Lifestyle considerations: Arava's once-daily oral dosing suits patients who prefer the simplicity of pill-based regimens over injections. However, its long half-life means it remains in the system for extended periods, which requires consideration if planning pregnancy or managing side effects.

Co-existing conditions: For patients with significant liver issues, hydroxychloroquine might be preferable to Arava. Conversely, patients with retinal concerns might find Arava more suitable than hydroxychloroquine, which requires regular eye examinations.

Treatment history: Patients who have failed methotrexate due to efficacy often try Arava before advancing to biologics, while those who couldn't tolerate methotrexate due to gastrointestinal effects might still respond well to Arava.

Common Side Effects and Management Strategies

When starting Arava, many patients experience transient digestive symptoms. For instance, Mrs. Zhang, a 50-year-old office worker, noticed mild diarrhea and nausea during her first three weeks on Arava. Her rheumatologist suggested taking the medication with food and temporarily prescribed an anti-nausea medication. By the fourth week, these symptoms had significantly improved.

Other commonly reported effects include:

  • Mild hair thinning (usually reversible and less severe than with methotrexate)
  • Elevated blood pressure (requiring regular monitoring)
  • Headaches and dizziness (often improving with continued use)
  • Skin rash or itching (requiring medical evaluation)

These effects typically diminish after the initial few weeks as your body adjusts to the medication. Maintaining good hydration and taking Arava with meals can help minimize digestive complaints.

Recognizing Serious Side Effects Requiring Immediate Action

While less common, certain side effects require prompt medical attention. These include:

Liver effects: Leflunomide can cause liver enzyme elevations and rarely more serious liver injury. Mr. Tan, a 62-year-old with controlled diabetes, developed unusual fatigue, dark urine, and yellowing of the eyes six months after starting Arava. He immediately contacted his physician, who ordered liver function tests and temporarily stopped the medication.

Respiratory symptoms: New or worsening cough, chest pain, or shortness of breath could indicate lung inflammation, a rare but serious complication.

Blood disorders: Unusual bruising, bleeding gums, or frequent infections might signal effects on blood cell production.

Peripheral neuropathy: Persistent tingling, numbness, or burning sensations in hands or feet should be reported promptly.

In Singapore, regular monitoring typically includes blood tests every 4-8 weeks initially, then every 8-12 weeks once stabilized on therapy.

Critical Medication Interactions to Avoid

Certain medication combinations require careful management:

Consider Ms. Liu, a 45-year-old rheumatoid arthritis patient who also manages high cholesterol. When her primary care physician prescribed cholestyramine for her cholesterol, she experienced a sudden flare of arthritis symptoms. Her rheumatologist identified that cholestyramine had accelerated the elimination of leflunomide from her system, reducing its effectiveness.

Other significant interactions include:

  • NSAIDs (increased risk of liver effects and GI issues)
  • Live vaccines (avoid during treatment due to immunosuppression)
  • Certain antibiotics like rifampin (may alter leflunomide levels)
  • Warfarin and other anticoagulants (requiring closer monitoring)

Always inform all healthcare providers about your Arava treatment before starting any new medication.

Optimizing Treatment: Dosing and Administration Guidelines

The typical Arava treatment regimen begins with a loading dose of 100mg daily for three days, followed by a maintenance dose of either 10mg or 20mg once daily. However, in Singapore, many rheumatologists now skip the loading dose approach to reduce initial side effects, starting directly with the maintenance dose.

For optimal absorption, Arava can be taken with or without food, though taking it with meals often helps reduce stomach upset. The medication should be swallowed whole with a full glass of water, not crushed or chewed.

Treatment response varies individually. Most patients begin noticing improvements in pain and stiffness within 4-6 weeks, though maximum benefits may take up to 6 months to develop. During this initial period, your doctor may recommend continuing other medications like NSAIDs or low-dose prednisone as bridging therapy.

If side effects occur, dose adjustment may help. For instance, some patients who experience side effects on 20mg daily do well when reduced to 10mg daily, or alternatively, 20mg every other day. These adjustments should always be made under medical supervision.

Missing a single dose isn't typically concerning due to leflunomide's long half-life. If you miss one day, simply continue with your regular schedule without doubling up. However, consistent adherence produces the most reliable results.

Accessing Arava in Singapore: Availability and Prescription Requirements

In Singapore, Arava is classified as a prescription-only medication available through hospital pharmacies, polyclinic pharmacies, and licensed private retail pharmacies. The medication is typically prescribed by specialists, particularly rheumatologists, though some general practitioners with experience in managing rheumatoid arthritis may also prescribe it for established patients.

Arava is listed on the Standard Drug List and is eligible for subsidy under the Medication Assistance Fund (MAF) for qualified patients at restructured hospitals and polyclinics. With appropriate subsidies, eligible patients might pay significantly less than the private retail price. Additionally, MediSave can be used for chronic disease management, potentially covering part of the medication cost.

Most major insurance plans in Singapore cover Arava, subject to the plan's formulary and prior authorization requirements. Patients should verify coverage details with their insurance provider, as some plans may require documentation of previous treatment failure with methotrexate.

Collaborative Conversations with Your Healthcare Provider

When discussing Arava with your healthcare provider, come prepared with specific questions and observations. Consider these approaches:

  1. Document your symptoms using a daily diary for the two weeks before your appointment, noting duration of morning stiffness, pain levels, and activity limitations.

  2. Ask specific questions about expectations: "How long should I try Arava before determining if it's working for me?" or "What specific improvements might indicate the medication is effective?"

  3. Discuss monitoring requirements: "What tests will I need regularly, and can these be scheduled conveniently?"

  4. Address fertility concerns directly if relevant: "I may want to consider pregnancy in the futureโ€”what would that mean for my Arava treatment?"

  5. Inquire about combination therapy: "Would combining Arava with my current medications provide better results?"

Personal Importation Guidelines for Leflunomide Medications

Singapore has specific regulations governing personal importation of prescription medications. For leflunomide products:

Patients may import a maximum 3-month supply for personal use with proper documentation, including:

  • A valid prescription from a Singapore-licensed physician
  • Original packaging with clear labeling
  • Declaration upon arrival at customs

However, importing medications to save costs carries risks, including potential counterfeit products or quality issues. The Health Sciences Authority (HSA) strongly recommends obtaining medications through licensed local healthcare facilities to ensure authenticity and appropriate monitoring.

If traveling abroad while on Arava therapy, carry a doctor's letter explaining your need for the medication, keep it in original packaging, and research destination country regulations regarding prescription medications.

Frequently Asked Questions About Arava and Leflunomide

Can I switch between Arava and generic leflunomide during treatment? Yes, switching is generally medically acceptable as both contain the same active ingredient. However, inform your doctor when switching to monitor for any unexpected changes in efficacy or side effects. Some patients report subtle differences when changing between formulations.

How does the cost of Arava compare with other rheumatoid arthritis treatments in Singapore? Arava typically costs more than conventional DMARDs like methotrexate or sulfasalazine, but substantially less than biologic therapies. After subsidies, the monthly cost may range from S$80-150 depending on dose and eligibility status, compared to S$20-60 for methotrexate and S$1,500+ for most biologics.

If I experience hair thinning with Arava, will it reverse? Hair thinning affects approximately 10% of patients taking leflunomide and typically begins 3-6 months after starting treatment. For most patients, this effect is mild and stabilizes over time, with regrowth occurring either during continued treatment or after discontinuation. Using gentle hair care products and avoiding harsh chemical treatments can help manage this side effect.

How long will I need to take Arava? Rheumatoid arthritis typically requires long-term management. If Arava effectively controls your symptoms without significant side effects, treatment often continues indefinitely. Some studies have explored dose reduction in patients with sustained remission, but medication changes should always be supervised by your rheumatologist.

What happens if I need to stop Arava quickly? Due to leflunomide's long half-life, an elimination procedure using cholestyramine or activated charcoal may be recommended if rapid clearance is necessary (such as for pregnancy planning or serious side effects). This washout process requires medical supervision and specific dosing protocols to accelerate elimination.

Making Informed Decisions About Your Arthritis Treatment

Arava represents an important option in Singapore's rheumatoid arthritis treatment landscape, offering an effective alternative for patients who cannot take or haven't responded adequately to methotrexate. Its once-daily oral dosing provides convenience, while its different mechanism of action may benefit those who haven't achieved control with other DMARDs.

When considering Arava versus its generic counterparts, most patients can expect similar clinical outcomes at potentially lower costs with generic leflunomide. However, individual factors including insurance coverage, sensitivity to inactive ingredients, and personal preference may influence this decision.

Remember that rheumatoid arthritis management extends beyond medicationโ€”regular exercise, joint protection techniques, and overall health maintenance all contribute to better outcomes. Partnering with your healthcare team to monitor both medication effects and overall disease activity ensures you receive optimized, personalized care.

Ultimately, the decision about Arava or any arthritis medication should balance effectiveness, safety, cost, and convenience within the context of your specific situation. With this knowledge, you're better equipped to engage in productive conversations with your healthcare providers and play an active role in managing your arthritis care.

External Resources about Arava


Information Prepared By

Nawin Kittisak
Vikneswaran V Paranjothy